Editing Bluephage
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1: | Line 1: | ||
Bluephage's, patented, microbiological testing kits developed at University of Barcelona, easily detect Coliphages in water (newly recognized as viral indicators of un-safe water). Distributing to 15 countries globally, Bluephage are well placed to enter the €1.4 billion (2022) water testing market. | Bluephage's, patented, microbiological testing kits developed at University of Barcelona, easily detect Coliphages in water (newly recognized as viral indicators of un-safe water). Distributing to 15 countries globally, Bluephage are well placed to enter the €1.4 billion (2022) water testing market. | ||
Line 8: | Line 6: | ||
* Distributing to 12 EU countries, Singapore, South Africa & Georgia | * Distributing to 12 EU countries, Singapore, South Africa & Georgia | ||
== | ==Idea== | ||
<vimeo> | <html> | ||
<iframe width="560" height="315" src="https://player.vimeo.com/video/592037036?h=b92091a596" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe> | |||
</html> | |||
Bluephage was founded in 2016 as a spin-off from the University of Barcelona by renowned researchers from the Health-Related Water Microbiology Research Group (MARS). | Bluephage was founded in 2016 as a spin-off from the University of Barcelona by renowned researchers from the Health-Related Water Microbiology Research Group (MARS). | ||
Line 24: | Line 24: | ||
For everyone, for the planet, help us fight the water crisis! | For everyone, for the planet, help us fight the water crisis! | ||
==Team | ==Team== | ||
Bluephage's team of world-renowned experts in basic and applied microbiology and virology, tapping into years of knowledge and know-how honed at the University of Barcelona within the MARS research group who developed the patent. | Bluephage's team of world-renowned experts in basic and applied microbiology and virology, tapping into years of knowledge and know-how honed at the University of Barcelona within the MARS research group who developed the patent. | ||
Line 40: | Line 40: | ||
Mireia Azuara, Chief Press Officer (Part-time CPO) Specialized in corporate communication and sustainable communication strategies. | Mireia Azuara, Chief Press Officer (Part-time CPO) Specialized in corporate communication and sustainable communication strategies. | ||
==Actions== | ==Actions== | ||
Line 52: | Line 45: | ||
To contact Bluephage, click [mailto:info@bluephage.com here]. | To contact Bluephage, click [mailto:info@bluephage.com here]. | ||